AXIBO Trademark

Trademark Overview

On Friday, September 30, 2011, a trademark application was filed for AXIBO with the United States Patent and Trademark Office. The USPTO has given the AXIBO trademark a serial number of 85436504. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 29, 2014. This trademark is owned by Glaxo Group Limited. The AXIBO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
axibo

General Information

Serial Number85436504
Word MarkAXIBO
Filing DateFriday, September 30, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 29, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 29, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 29, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2014EXTENSION 3 GRANTED
Monday, February 17, 2014EXTENSION 3 FILED
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, August 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2013EXTENSION 2 GRANTED
Wednesday, August 14, 2013EXTENSION 2 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2013EXTENSION 1 GRANTED
Wednesday, February 13, 2013EXTENSION 1 FILED
Monday, February 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 13, 2013TEAS EXTENSION RECEIVED
Tuesday, August 28, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 13, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, July 6, 2012CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, June 25, 2012ASSIGNED TO PETITION STAFF
Friday, June 15, 2012TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, March 28, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2012ASSIGNED TO LIE
Saturday, January 7, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2012ASSIGNED TO EXAMINER
Thursday, October 6, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 4, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

axibo pharmaceutical disorders treatment preparations substances diseases ophthalmic respiratory oncological cardiopulmonary